SAVE THE DATE!
January 8–10, 2024,
San Francisco, CA
SPOTLIGHT ON: NOVOTECH
Novotech is internationally recognized as the leading regional full-service contract research organization (CRO) in Asia-Pacific. Novotech has been instrumental in the success of over 1,200 Phase I - IV clinical trials for biotechnology companies across a range of therapeutic areas and indications. Novotech has a unique in-house capability through BioDesk - an expert global product development and regulatory affairs consultancy that supports intelligent development for global programs from bench to market.
RUNNING CLINICAL STUDIES IN ASIA-PACIFIC FROM EARLY TO LATE-STAGE TRIALS –
WHY BIOTECH COMPANIES ARE INCREASINGLY HEADING TO THE REGION
Global Data Report